{"path":"Images/Pasted image 20240418151110.png","text":"RM (Y/N) No No No No Yes No Yes Yes, every 30 min Fioz (%) 03 0.3and 17 0.4 0.4 0.5 0.4 0.46 (o) Standard ventilation, SV (n) Vi (mlkg) -IBW 15 12-15 12 12 10 12 9 10-12 PEEP ((mH,0) 0 0 0 0 0 5 0 0 RM No No No No No No No No Fioz (%) 03 03and1° 04 0.4 05 05 04 0.47 (o) Primary outcome Intraoperative Intraoperative Intraoperative IntraoperativeCC16 Intraoperative (TWA) FVC mCPIS Major pulmonary and cytokine cytokine BAL: coagulation Pao,/Fio, (TWA) FEV, extrapulmonary plasma level plasma and (TAT), MPO, IL over5d complications tracheal and cytokines over 7d aspirates levels levels Results No difference No difference TATand MPO | PV No difference 1 PV group No difference | PV groupat | PV group (RR = 0.4, group; No POD1and 95% Cl 0.24-0.68) differences in POD 3 other cytokines Abbreviations: ASA, American Society of Anesthesiologists score; BAL, bronchoalveolar lavage; CC16, Clara cell protein; Cl, confidence interval; EBL, estimated blood loss; IBW, ideal body weight; IV, intravenous; mCPIS, Modified Clinical Pulmonary Infection Score'®; MPO, myeloperoxidase; NR, not reported; OLV, one-lung ventilation; POD, postoperative day; RCT, randomized controlled trial; RL, Ringer lactate; RM, recruitment maneuvers; RR, relative risk; SC, subcutaneous; TAT, thrombin-antithrombin; (TWA) FEV;, time-weighted average forced expiratory volume in 1 second; (TWA) FVC, time-weighted average forced vital capacity. 2 Postoperative pneumonia risk index greater than 2.\"* Adapted from Coppola S, Froio S, Chiumello D. Protective lung ventilation during general anesthesia: is there any evidence? Crit Care 2014;18(2):210.","libVersion":"0.3.2","langs":"eng"}